Sciele Pharma Inc. v. Lupin Ltd.

Opinion

NOTE: This order is nonprecedential United States Court of AppeaIs for the FederaI Circuit SCIELE PHARMA INC. (NOW KNOWN AS SHIONOGI PHARMA INC.), ' Plaintiff-Appellee, AND ANDRX CORPORATION, ANDRX PHARMACEUTICALS INC. (DOING BUSINESS AS WATSON LABORATORIES INC. - FLORIDA), ANDRX PHARMACEUTICALS L.L.C., ANDRX LABORATORIES (NJ) INC., ANDRX EU LTD., AND ANDRX LABS L.L.C., Plaintiffs, V. LUPIN LTD. AND LUPIN PHARMACEUTICALS INC., Defendants-Appellan,ts, AND MYLAN INC. AND MYLAN PHARMACEUTICALS INC., Defendants. 2012-1228

SClELE PHARMA v. LUPIN LTD 2 Appeal from the United States District Court for the District of De1aWare in consolidated case no. 09-CV-0037, Judge Robert B. Kugler. ON MOTION ORDER Upon consideration of the February 27, 2012 order expediting briefing on the merits of this appeal, IT IS ORDERED THAT: Oral argument for the merits of the appeal is sched- uled to be held at 2 p.m., April 18, 2012 in Courtroom 402 The parties shall notify the clerk in writing of the name of the counsel who will present oral argument no later than Apri16, 2012. FoR THE CoURT 2 8 2012 /s)' Jan Horbaly Date J an Horbaly Clerk FILED "'SiE¢%‘l§l9§llF&E‘§bi¥°" cc: David B. Bassett, Esq. " “` ' Douglass C. Hochstetler, Esq. MAR 2 5 2012 33 .1ANHnaaAw C\.EHK